Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20121
20132
20141
20151
20161
20172
20181
20191
20211
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AvenCell Therapeutics, Inc.1
BeOne Medicines1
Celgene1
Epizyme, Inc.1
Fred Hutchinson Cancer Center1
Genentech, Inc.1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1
Hoffmann-La Roche1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Follicular8
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin4
Burkitt Lymphoma3
Lymphoma3
Lymphoma, B-Cell3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hodgkin Disease2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.